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Introduction: We sought to examine the impact of preexisting and new onset renal disease on burn
injury mortality.
Methods: Retrospective analysis of patients admitted to a regional burn center from 2002-2012 was
performed. Variables analyzed included demographics, burn mechanism, inhalation injury status, and %
TBSA. Poisson regression was performed to estimate risk of in-hospital burn mortality.
Results: There were a total of 7640 patients over the study period. The adjusted 60-day risk of in-hospital
mortality in patients with preexisting renal disease (PRD was 3 times higher compared to patients with
no preexisting renal disease (IRR¼ 3.22, 95% CI¼ 1.26e8.25). The adjusted 60-day risk of mortality is 2
times higher for patients with new onset renal disease compared to those without (IRR¼ 2.11, 95%
CI¼ 1.55e2.87).
Conclusion: Preexisting and new onset renal disease results in a significantly higher risk of mortality
following burn injury compared to patients without renal disease. Prevention of new onset renal injury
and careful management of patients with preexisting renal disease to prevent exacerbation should be
pursued.1. Introduction
In the United States, 23 to 30 million adults have chronic kidney
disease (CKD) with millions of others at increased risk.1,2 Chronic
kidney disease is defined as any condition that causes reduced renal
function over a long period of time.3 Diagnosis is based on the
estimated glomerular filtration rate (GFR), the rate at which kidney
filter waste, and proteinuria, the amount of protein present in the
urine. There are five stages of CKD ranging from kidney damage
with normal function to end-stage renal disease (ESRD) requiring
dialysis or transplantation. The two main risk factors for CKD are
diabetes mellitus and hypertension. Individuals with preexisting
CKD and concomitant diabetes or cardiovascular disease have
increased risk of mortality.3 Specifically, adults with CKD have
higher incidence of premature death from cardiovascular disease
compared to matched cohorts without CKD.2,4
Acute renal failure (ARF), characterized by sudden loss of the
ability of the kidneys to excrete waste, concentrate urine, conserveUniversity of North Carolina,
les).electrolytes, and maintain fluid homeostasis, is a frequent clinical
problem. In the critical care setting it is associated with a mortality
of between 50% and 80%.5 The etiopathogenesis of acute kidney
injury varies depending on preexisting medical conditions, hemo-
dynamic changes, and the presence of sepsis.6 ARF is one of the
major burn complications and is accompanied by high mortality. In
burns, most ARF occurs either immediately after injury or with
delayed presentation when sepsis develops.
Previously published studies have investigated the effects of ARF
on burn injury mortality but no other study has examined the
impact of preexisting renal disease on burn injury mortality. We
therefore sought to examine the impact of both preexisting and
new onset renal disease on burn injury outcomes. We hypothesize
that pre-existing and new onset renal disease will result in
increased in-hospital mortality following burn injury compared to
patients with the absence of renal disease.2. Methods
This is a retrospective study of all burn patients admitted to the
North Carolina Jaycee Burn Center from 2002 to 2012. The North
Carolina Jaycee Burn Center at the University of North Carolina is an
American Burn Association verified pediatric and adult center. The
center, established in 1981, is a 36-bed single unit facility, which
averages more than 1200 acute admissions per year.
The medical records of subjects identified by the UNC Burn
database query were reviewed to verify baseline demographic data,
injury characteristics, and provide medical comorbidities and
complications information. For this study, patients <18 years were
excluded. In addition, patients with preexisting renal disease were
excluded in the secondary analysis for effects of new onset renal
disease. Injury characteristics of interest included burnmechanism,
%TBSA burn, presence of inhalation injury, and ventilator status on
admission to the burn center. Inhalation injury diagnosis was based
on history, physical examination, and/or bronchoscopic examina-
tion. All patients in the ICU were treated with the same standard of
care (i.e. ventilator management, fluid resuscitation, dialysis use,
etc.) at a large academic burn center over the time period of the
study. Pre-existing comorbidities were obtained from medical re-
cords, as well as history reported by the patient, family, or friends
privy to patient's history upon admission to the burn center. The
exact cause of death for patients in this cohort is not recorded in the
burn registry.
To examine the effect of baseline medical comorbidities on
outcome, a Charlson Comorbidity Index (CCI) score was calculated
for each patient. The standardized Charlson Index has been re-
ported to accurately predict the probability of mortality within one
year for a number of medical conditions.7,8 The score is the
weighted sum of 17 comorbid conditions, each of which is assigned
a weight from 1 to 6 points.9 The CCI was modified for this study to
exclude renal disease in order to elicit the independent effect of
renal disease on burn outcome. Pre-existing comorbidities were
identified and recorded based on ICD-9 codes.
The primary outcome of interest in this study was in-hospital
mortality. Baseline patient and injury characteristics wereTable 1
Patient demographics and burn characteristics of adult patients, stratified by re
Preexisting Renal Disease 102 (1.9












Age, in years, median (IQR) 61 (50e70)
mCCI, median (IQR) 3 (2e3)
Comorbidities, n (%)
Diabetes 63 (61.8)
Prior myocardial infarction 11 (10.8)
Burn mechanism, n (%)
Flame 48 (47.5)
Scald 48 (47.5)
Other burn 5 (5.0)
Unknown 11
TBSA, median (IQR) 5 (2e12)
Inhalation injury, n (%) 13(12.7)
Dialysis requirement, n(%) 15(14.7)
Sepsis 19 (18.6)
Crude in-hospital mortality 18 (17.6)
Hospital LOS, median (IQR) 23.6(9.0e43.4)
Abbreviations: IQR, interquartile range; mCCI, Charlson Comorbidity Index exc
stay.
a Chi-square and ANOVA tests were used to calculate overall p-values; p < 0compared between groups (preexisting renal disease (PRD) versus
no preexisting renal disease (NPRD) and new onset renal disease
(NORD) versus no renal disease (NK)) using Analysis of Variance for
continuous variables and chi-squared for discrete variables. A two-
sided p-value < 0.05 was considered statistically significant. We
employed both univariate and multivariate models to determine
the relative influence of renal disease on mortality after controlling
for covariates. To estimate the incidence risk ratios for mortality, we
used a multivariate Poisson regression model controlling for
pertinent confounders (age, %TBSA, mechanism of injury, presence
of inhalation injury, other comorbidities using CCI, race, and sex).
Age and %TBSA were modeled as multi-level categorical variables.
An interaction termwas created to reduce the impact of collinearity
between diabetes and renal disease. Sepsis was excluded in the
regression model because it was determined to be on the causal
pathway that leads to renal failure using a directed acyclic graph
(DAG).9
Stata/MP (Version 12) (Stata Corp, College Station, TX) was used
for all data management and statistical analysis. The University of
North Carolina Institutional Review Board approved this study.3. Results
3.1. The effect of preexisting renal disease
A total of 5330 patients 18 years old were admitted to during
the study period and included in analysis for preexisting renal
disease effects on burn injury mortality. Preexisting renal disease
(PRD) was present in 102 (2%) patients, which included chronic
renal failure (n¼ 56, 55%), end stage renal disease (n¼ 15,15%), and
chronic glomerulonephritis (n¼ 30, 29%). Of those with PRD, 15%
were dialysis dependent. Patients with PRD were more likely to be
older (median age 61 vs 41, p< 0.001) and black (57% vs 25%,nal disease status.




























luding renal disease; TBSA, total burn surface area; LOS, length of hospital
.05 are in bold.
Table 2
Crude and adjusted effect of preexisting renal disease on inpatient mortality.
HR 95% CIa p-value
Crude (overall) 3.49 2.26, 5.39 <0.0001
30 day 3.31 1.71, 6.41 <0.001
60 day 2.99 1.70, 5.27 <0.001
Adjustedb (overall) 1.93 0.93, 4.03 0.076
30 day 3.71 1.47, 9.38 0.006
60 day 3.22 1.26, 8.25 0.015
Abbreviations: IRR, incidence rate ratio; CI, confidence interval.
a Estimated using a robust variance sandwich estimator.
b Multivariable regression controlling for sex, age, race/ethnicity, non-renal
comorbidities using Charlson Comorbidity Index, burn mechanism, total burn sur-
face area (TBSA), dialysis use and inhalational injury; An interaction term was
created to reduce the impact of collinearity between preexisting diabetes and renal
disease. Age and TBSA were modeled as multi-level categorical variables.p< 0.001) compared to patient with NPRD (Table 1). There was no
significant difference between the two groups in %TBSA, sex,
mechanism of injury, or presence of inhalation injury. Patients with
PRD had a higher Charlson Comorbidity Index (2.4 vs. 0.4,
p< 0.001) and were more likely to have a history of diabetes mel-
litus (62% vs.10%, p< 0.001) and/or prior myocardial infarction (11%
vs 2%, p< 0.001). Approximately 15% (vs. 2% for NPRD) of patients
with PRD had cardiac complications and 19% (vs 2.8% for NPRD)
developed sepsis (p< 0.001). Patients with PRD had statistically
significant longer hospital length of stay with a median 23.6 days
(IQR 9e43.4) compared to NPRD patients with a median of 7 days
(IQR 2.0e14.6, p< 0.001).
The crude mortality rate was higher for patients with PRD
compared to NPRD (18% vs. 5%, p< 0.001). A multivariable Poisson
regression model was utilized to determine the incidence risk of
burn injury mortality in the PRD vs. NPRD subgroups after adjust-
ing for significant covariates. The adjusted incidence risk ratios
(IRR) for in-hospital mortality were significantly higher at 30 and
60 days for patients with PRD versus NPRD patients at 3.71 (95%
CI¼ 1.47e9.38) and 3.22 (95% CI¼ 1.26e8.25), respectively
(Table 2). The cumulative risk of in-hospital mortality was higher
for patients with preexisting renal disease within the 60 days of
admission compared to healthy renal patients, with or without
inhalation injury (Fig. 1). Although the overall adjusted mortality
incidence for the PRD cohort was almost 2 times higher (IRR¼ 1.93
(NPRD reference group), 95% confidence interval: 0.93e4.03), thisFig. 1. The cumulative risk of in-hospital mortality for patients with preexisting renal
disease within the 60 days of admission compared to healthy renal patients, with or
without inhalation injury.was not statistically significant.
3.2. New onset renal disease
After exclusion of patients with preexisting renal disease
(n¼ 102), a total of 7539 patients were analyzed to determine the
effect of new onset renal disease on burn injury mortality. Of this
cohort 194 (2.6%) developed new onset renal disease, which
included acute renal failure (n¼ 189, 97%), acute tubular necrosis
(n¼ 74, 38%), and acute glomerulonephritis (n¼ 6, 3%). In a bivar-
iate analysis, patients with NORD were more likely to be older
(median age 53 vs 30, p< 0.001), black (41% vs 27%, p< 0.001). In
addition, the NORD cohort also had a higher %TBSA (median 25 (IQR
9e45) % vs. 5 (IQR 2e10) %, p< 0.001) and was more likely to suffer
a flame injury (75% vs 45%, p< 0.001) compared to patient who
developed no renal disease (NK) (Table 3). In terms of othermedical
comorbidities, patients with NORD had a higher Charlson Comor-
bidity Index (1.1 vs 0.3, p< 0.001) and were more likely to have a
history of diabetes mellitus (18% vs 7%, p< 0.001) or prior
myocardial infarction (9% vs 1%, p< 0.001) compared to the NK
cohort. Approximately, 40% (vs 1.1% of NK) of patients with NORD
developed sepsis (p< 0.001). Patients with NORD had statistically
significant longer hospital length of stay (median 45 days (IQR
19e82)) vs. 5 days (IQR 1.6e11.8), p< 0.001)) compared to NK
cohort.
The crude in-hospital mortality ratewas higher for patients with
NORD (37% vs 3%, p< 0.001). After adjustment for other covariates
utilizing amultivariable Poisson regression, the incidence risk of in-
hospital mortality at 30 and 60 days for the NORD versus NK co-
horts were 2.66 (CI¼ 1.75e4.05) and 2.11 (CI¼ 1.55e2.87)
(Table 4). The cumulative risk of in-hospital mortality was higher
for patients who developed NORD within the 60 days of admission
compared to patients with no renal issues, particularly in the
presence of inhalation injury (Fig. 2). Also, the overall NORD
adjusted mortality incidence was almost 2.3 times higher
(IRR¼ 2.34 (NK reference group), 95% confidence interval:
1.77e3.04).
4. Discussion
In this study, we have shown burn patients with preexisting and
new onset renal disease have a significantly higher incidence of in-
hospital mortality compared to burn patients with a history of no
renal disease.
There have been no previous studies that have examined the
effects of preexisting renal disease on burn injury outcomes.
However, multiple studies reveal that AKI is prevalent and associ-
ated with increased burn mortality. A systemic review and meta-
analysis of published burn articles between 1960 and 2009,
revealed a 3-to-6-fold increase in mortality for AKI patients.10
When defined based on the Risk, Injury, Failure, Loss and End-
stage kidney disease (RIFLE) criteria, 25% of patients with severe
burn injury develop AKI with a median mortality of 34.9%. For
patients who required renal replacement therapy, the median
mortality was almost 80%.12 In our burn cohort, the crude mortality
for patients who developed new onset renal disease was 37%. The
cause of AKI may be the determinant factor in burn injury survival.
A previous study on sepsis found a direct relationship between
the patient response to treatment and the occurrence of AKI.11 In
patients with confirmed positive blood cultures, AKI occurs in
about 19% patients with moderate sepsis, 23% with severe sepsis,
and 51% with septic shock.12 Sepsis is the leading cause of death in
burn patients and is concomitant in 87% of burn patients with
AKI.13,14
Renal failure has been shown to occur during two periods after
Table 3
Patient demographics and burn characteristics of adult patients, stratified by renal complication status.
New onset renal disease 194 (1.9%) No renal disease 7345 (98.1%) p-valuea
Hospitalization year, n (%) <0.001
2002e2005 55 (28.3) 1885 (25.7)
2006e2009 70 (36.1) 2486 (33.8)
2010e2012 69 (35.6) 2974 (40.5)
Sex, n (%) 0.224
Male 141 (72.7) 5037 (68.6)
Female 53 (27.3) 2308 (31.4)
Race/ethnicity, n (%) <0.001
White 87 (44.8) 3772 (51.4)
Black 79 (40.7) 1994 (27.2)
Hispanic 8 (4.1) 652 (8.8)
Other 20 (10.3) 924 (12.6)
Age, in years, median (IQR) 53 (37e64) 30 (11e47) <0.001
mCCI, median (IQR) 3 (2e3) 0 (0e0) <0.001
Comorbidities, n (%)
Diabetes 34 (17.5) 502 (6.8) <0.001
Prior myocardial infarction 18 (9.3) 101 (1.4) <0.001
Burn mechanism, n (%) <0.001
Flame 145 (75.5) 3260 (44.7)
Scald 35 (18.2) 3604 (49.1)
Other burn 12 (6.3) 434 (5.9)
Unknown 2 47 e
TBSA, median (IQR) 25 (9e45) 5 (2e10) <0.001
Inhalation injury, n (%) 72 (37.3) 494 (6.7%) <0.001
Dialysis requirement, n(%) 1(<1) 0 (0) <0.001
Sepsis 78 (40) 79 (1.1) <0.001
Crude in-hospital mortality 72 (37.0) 199 (2.7) <0.001
Hospital LOS, median (IQR) 45.4 (19.0e82.0) 5.0 (1.6e11.8) <0.001
Abbreviations: IQR, interquartile range; mCCI, Charlson Comorbidity Index excluding renal disease; TBSA, total burn surface area; LOS, length of hospital stay.
a Chi-square and ANOVA tests were used to calculate overall p-values; p < 0.05 are in bold.burn injury. The first period is immediately due to burn shock, a
unique combination of distributive and hypovolemic shock man-
ifested by intravascular volume depletion, low pulmonary artery
occlusion pressures, elevated systemic vascular resistance, and
depressed cardiac output.15,16 The second period has a delayed
presentation and is usually due to gram-negative sepsis. The
pathophysiology of gram-negative sepsis is initiated when the
endotoxin lipopolysaccharide (LPS) induces proinflammatory cy-
tokines such as tumor necrosis factor (TNF) that binds to receptors
on the glomerular endothelial cell and renal tubular epithelial
cells.17,18 Nitric oxide (NO) synthase is induced after a chain of re-
action resulting in the formation of NO. In large quantities, NO is
responsible for the systemic vasodilation seen during sepsis and as
a result, leads to septic shock.19 The renal system tries to
compensate for the volume depletion with vasoconstriction and
water retention, which results in a decrease in GFR.20 It is common
to associate hemodynamic factors such as hypotension with AKI
seen in severe sepsis patients.Table 4
Crude and adjusted effect of new onset renal disease on inpatient mortality.
HR 95% CIa p-value
Crude (overall) 13.57 10.80, 17.06 <0.0001
30 day 14.86 11.28, 19.57 <0.001
60 day 15.78 11.30, 22.03 <0.001
Adjustedb (overall) 2.31 1.77, 3.04 <0.001
30 day 2.66 1.75, 4.05 <0.001
60 day 2.11 1.55, 2.87 <0.001
Abbreviations: IRR, incidence rate ratio; CI, confidence interval.
a Estimated using a robust variance sandwich estimator.
b Multivariable regression controlling for sex, age, race/ethnicity, non-renal
comorbidities using Charlson Comorbidity Index, burn mechanism, total burn sur-
face area (TBSA), and inhalational injury; An interaction term was created to reduce
the impact of collinearity between diabetes and renal disease. Age and TBSA were
modeled as multi-level categorical variables.The ability to predict acute renal failure is still challenging. In a
multivariable regression, both burn size and septicemia were the
only significant predictors of acute renal failure.21 The initial indi-
cation of altered renal function in the clinical setting for either
acute on chronic or new acute renal failure is oliguria. In the early
phase of burn care, it is imperative that hypovolemia is treatedwith
balanced fluid resuscitation ensuring the attainment of an adequate
cardiac preload.22 The use of colloid fluids in combination with
crystalloids as part of a goal direct resuscitation strategy may be
helpful. In addition, the use of heart rate, blood pressure, and urine
output, as well as diagnostic adjuncts such as echocardiography to
visualize the inferior vena cava and assess cardiac contractility andFig. 2. The cumulative risk of in-hospital mortality for patients who developed New
onset Renal disease (NORD) within the 60 days of admission compared to patients
with no renal issues (NK), with or without inhalation injury.
wall motion abnormalities, can help dictate the need for
vasopressors.
In comparison, acute kidney injury that is sequelae of sepsis is
part of multiple organ dysfunction. Standard protocol of sepsis
treatments such as early goal directed therapy, obtaining cultures,
source control, administration of broad-spectrum antibiotics, and
glycemic control should be initiated. Secondary nephrotoxic injury
due to decrease renal perfusion or the use of nephrotoxic medi-
cations such as aminoglycoside and contrast agents must be pre-
vented. Utilizing renal dosing of medications to prevent new onset
renal disease or acute on chronic renal failure is essential. The
regular monitoring of renal function using serum urea and creati-
nine trends will help indicate renal recovery or need for dialysis. In
patients meeting the criteria for renal failure, renal replacement
therapy should be initiated as indicated. With advancements in
burn care management, there has been a reduction in the number
of patient with renal failure requiring RRT with a current incidence
between 1 and 3%.12,16
The limitations of this study are those inherent to any study
with a retrospective methodology. The pre-existing comorbidities
were abstracted from documented diagnosed based on ICD-9 codes
and hence subject to coding accuracy. Laboratory values such as
blood urea nitrogen, serum creatinine, and GFR were not available
in the registry to confirm the diagnosis and to calculate functional
excretion of sodium or urea to further delineate the characteristics
of the kidney injury. Only inpatient mortality was captured and
analyzed, which represents only a portion of all death caused by
burn injury. The contribution of frailty and its effect on outcome
was not evaluated in our analysis. Finally, this study only includes
patients from a single center study; however, the size of our burn
cohort studied strengthens our findings.
5. Conclusion
Preexisting and new onset renal disease results in a significantly
increased risk of mortality following burn injury compared to pa-
tients without renal disease. It is imperative to take into account
comorbidities, such as renal disease, in prognosticating burn injury
mortality outcomes. Further translational studies are needed to
find biomarkers indicating early kidney dysfunction and potential
therapeutic targets preventing further decline in renal function.
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